Corteva, Inc. (CTVA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Corteva, Inc. (CTVA) reported $6.46 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 5.6%. EPS of $2.20 for the same period compares to $1.83 a year ago.The reported revenue represents a surprise of +3.36% over the Zacks Consensus Estimate of $6.25 billion. With the consensus EPS estimate being $1.89, the EPS surprise was +16.4%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Seed: $4.54 billion versus $4.46 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +4.8% change.Revenue- Crop Protection: $1.92 billion versus $1.8 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +7.8% change.Revenue- Crop Protection- Other: $49 million compared to the $88.17 million average estimate based on two analysts. The reported number represents a change of -71.2% year over year.Revenue- Seed- Other: $133 million versus $168.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -8.3% change.Revenue- Crop Protection- Herbicides: $995 million versus $951.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.2% change.Revenue- Crop Protection- Insecticides: $436 million versus $413.11 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.1% change.Revenue- Crop Protection- Fungicides: $342 million versus the two-analyst average estimate of $261.53 million. The reported number represents a year-over-year change of +36.8%.Revenue- Seed- Soybean: $1.26 billion versus the two-analyst average estimate of $1.31 billion. The reported number represents a year-over-year change of -4.6%.Revenue- Seed- Corn: $2.96 billion versus the two-analyst average estimate of $2.74 billion. The reported number represents a year-over-year change of +10.4%.Revenue- Seed- Other oilseeds: $186 million versus the two-analyst average estimate of $218.94 million. The reported number represents a year-over-year change of 0%.Operating EBITDA- Seed: $1.86 billion compared to the $1.77 billion average estimate based on four analysts.Operating EBITDA- Corporate: $-33 million versus $-32.4 million estimated by four analysts on average.View all Key Company Metrics for Corteva, Inc. here>>>Shares of Corteva, Inc. have returned -5.4% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Corteva, Inc. (CTVA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks